Scroll Top

Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson’s Disease

Benzinga

Mar 06 2024

https://www.benzinga.com/general/biotech/24/03/37478966/exclusive-gain-therapeutics-highlights-lead-program-data-showcasing-its-impact-on-cellular-death-

Latest Articles

Clear Filters
October 14, 2024
Understanding the Therapeutic Potential of GT-02287 in GBA-Parkinson Disease
https://www.neurologylive.com/view/understanding-therapeutic-potential-gt-02287-gba-parkinson-disease
Read More
October 10, 2024
GT-02287 may slow Parkinson’s progression, new early data suggest
https://parkinsonsnewstoday.com/news/gt-02287-slow-parkinsons-progression-new-preclinical-data/
Read More
October 3, 2024
Parkinson’s therapy safely increases GCase activity in healthy volunteers
https://parkinsonsnewstoday.com/news/parkinsons-therapy-increases-gcase-activity-phase-1-trial/
Read More